Published in Cancers (Basel) on February 12, 2015
Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. Int J Radiat Oncol Biol Phys (2016) 0.82
Modeling Combined Chemotherapy and Particle Therapy for Locally Advanced Pancreatic Cancer. Front Oncol (2015) 0.80
Effects of Charged Particles on Human Tumor Cells. Front Oncol (2016) 0.77
Differential Superiority of Heavy Charged-Particle Irradiation to X-Rays: Studies on Biological Effectiveness and Side Effect Mechanisms in Multicellular Tumor and Normal Tissue Models. Front Oncol (2016) 0.75
Why RBE must be a variable and not a constant in proton therapy. Br J Radiol (2016) 0.75
The Role of Nuclear Fragmentation in Particle Therapy and Space Radiation Protection. Front Oncol (2016) 0.75
An analytical model of leakage neutron equivalent dose for passively-scattered proton radiotherapy and validation with measurements. Cancers (Basel) (2015) 0.75
Effects of ionizing radiation on DNA methylation: from experimental biology to clinical applications. Int J Radiat Biol (2017) 0.75
Charged-particle therapy in cancer: clinical uses and future perspectives. Nat Rev Clin Oncol (2017) 0.75
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet (2007) 9.88
Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med (2012) 8.46
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell (2004) 6.99
Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys (1997) 4.73
The role of apoptosis in cancer development and treatment response. Nat Rev Cancer (2005) 4.19
The calibration of CT Hounsfield units for radiotherapy treatment planning. Phys Med Biol (1996) 3.95
Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer (2009) 3.31
Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys (2002) 3.21
Range uncertainties in proton therapy and the role of Monte Carlo simulations. Phys Med Biol (2012) 2.74
Correlation between CT numbers and tissue parameters needed for Monte Carlo simulations of clinical dose distributions. Phys Med Biol (2000) 2.65
Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys (2001) 2.52
Mechanism of radiation-induced bystander effects: a unifying model. J Pharm Pharmacol (2008) 2.07
Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys (2013) 1.89
Charged particle therapy--optimization, challenges and future directions. Nat Rev Clin Oncol (2013) 1.70
Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses. Int J Radiat Oncol Biol Phys (2014) 1.64
Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer (2011) 1.55
Computation of cell survival in heavy ion beams for therapy. The model and its approximation. Radiat Environ Biophys (1997) 1.52
Induction and quantification of gamma-H2AX foci following low and high LET-irradiation. Int J Radiat Biol (2006) 1.48
Abscopal effect in a patient with melanoma. N Engl J Med (2012) 1.39
Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate. Phys Med Biol (2007) 1.35
Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res (2003) 1.32
Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res (2005) 1.30
Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol (2014) 1.30
Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha. Clin Cancer Res (2008) 1.29
Molecular therapy in head and neck oncology. Nat Rev Clin Oncol (2009) 1.24
A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol (1999) 1.24
Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles. Phys Med Biol (2002) 1.21
Significance and implementation of RBE variations in proton beam therapy. Technol Cancer Res Treat (2003) 1.20
Development of radiation therapy optimization. Acta Oncol (2000) 1.20
Range uncertainty in proton therapy due to variable biological effectiveness. Phys Med Biol (2012) 1.20
Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning. Int J Radiat Oncol Biol Phys (2010) 1.19
Cellular and molecular effects of protons: apoptosis induction and potential implications for cancer therapy. Apoptosis (2006) 1.18
Relative biological effectiveness of proton beams in clinical therapy. Radiother Oncol (1999) 1.17
Spectrum of complex DNA damages depends on the incident radiation. Radiat Res (2006) 1.17
Imaging features that discriminate between foci induced by high- and low-LET radiation in human fibroblasts. Radiat Res (2006) 1.16
Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans. Med Phys (2014) 1.16
Chromosomal instability in unirradiated hemaopoietic cells induced by macrophages exposed in vivo to ionizing radiation. Cancer Res (2008) 1.15
Elevated LET components in clinical proton beams. Phys Med Biol (2011) 1.14
Improvement of prostate treatment by anterior proton fields. Int J Radiat Oncol Biol Phys (2011) 1.12
In vivo proton range verification: a review. Phys Med Biol (2013) 1.11
Energy deposition stochastics and track structure: what about the target? Radiat Prot Dosimetry (2007) 1.10
Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer (2013) 1.10
The influence of metal artefacts on the range of ion beams. Phys Med Biol (2007) 1.09
New challenges in high-energy particle radiobiology. Br J Radiol (2014) 1.08
The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer. Phys Med Biol (2005) 1.07
Biological effects of proton radiation: what we know and don't know. Radiat Res (2013) 1.06
Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation. J Radiat Res (2012) 1.06
Immunofluorescence detection of clustered gamma-H2AX foci induced by HZE-particle radiation. Radiat Res (2005) 1.06
Inactivation of human normal and tumour cells irradiated with low energy protons. Int J Radiat Biol (2000) 1.05
Second cancers in children treated with modern radiotherapy techniques. Radiother Oncol (2008) 1.05
Efficient production of reactive oxygen species in neural precursor cells after exposure to 250 MeV protons. Radiat Res (2005) 1.04
A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes. Acta Oncol (2012) 1.03
Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc (2002) 1.01
Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment. Int J Radiat Oncol Biol Phys (2014) 1.01
Radiation response of cell organelles. Micron (2000) 1.00
The effect of radiation quality on genomic DNA methylation profiles in irradiated human cell lines. Radiat Res (2011) 1.00
In vivo proton beam range verification using spine MRI changes. Int J Radiat Oncol Biol Phys (2010) 1.00
Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res (2003) 1.00
Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy. Int J Radiat Oncol Biol Phys (2010) 0.98
Theory of RBE for heavy ion bombardment of dry enzymes and viruses. Radiat Res (1967) 0.97
Induction of in situ DNA double-strand breaks and apoptosis by 200 MeV protons and 10 MV X-rays in human tumour cell lines. Int J Radiat Biol (2010) 0.97
Radiogenomics predicting tumor responses to radiotherapy in lung cancer. Semin Radiat Oncol (2010) 0.97
Calculation of the uncertainty in the dose delivered during radiation therapy. Med Phys (1985) 0.96
Immunologically augmented cancer treatment using modern radiotherapy. Trends Mol Med (2013) 0.95
Cell cycle perturbations and genotoxic effects in human primary fibroblasts induced by low-energy protons and X/gamma-rays. J Radiat Res (2009) 0.94
Sensitivity of intensity modulated proton therapy plans to changes in patient weight. Radiother Oncol (2008) 0.94
A mechanism-based approach to predict the relative biological effectiveness of protons and carbon ions in radiation therapy. Int J Radiat Oncol Biol Phys (2011) 0.94
Benchmarking nuclear models of FLUKA and GEANT4 for carbon ion therapy. Phys Med Biol (2010) 0.93
Cell membrane oxidative damage induced by gamma-radiation and apoptotic sensitivity. J Environ Pathol Toxicol Oncol (2004) 0.92
Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay. Int J Radiat Oncol Biol Phys (2010) 0.92
Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice. J Radiat Res (2005) 0.92
Therapy-resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation. J Thorac Oncol (2013) 0.92
Proton irradiation suppresses angiogenic genes and impairs cell invasion and tumor growth. Radiat Res (2012) 0.90
Evaluation of lesion clustering in irradiated plasmid DNA. Int J Radiat Biol (2005) 0.89
Induction of cell death through alteration of oxidants and antioxidants in lung epithelial cells exposed to high energy protons. J Biol Chem (2010) 0.88
Low energy proton beam induces tumor cell apoptosis through reactive oxygen species and activation of caspases. Exp Mol Med (2008) 0.88
The cell membrane as a biosensor of oxidative stress induced by radiation exposure: a multiparameter investigation. Radiat Res (2003) 0.87
Proton radiobiology, radiosurgery and radiotherapy. Int J Radiat Biol (1995) 0.86
Impact of variable RBE on proton fractionation. Med Phys (2013) 0.85
Empirical model estimation of relative biological effectiveness for proton beam therapy. Radiat Prot Dosimetry (2011) 0.85
Physical and biological factors determining the effective proton range. Med Phys (2013) 0.85
Distinct transcriptome profiles identified in normal human bronchial epithelial cells after exposure to γ-rays and different elemental particles of high Z and energy. BMC Genomics (2013) 0.85
Biological considerations when comparing proton therapy with photon therapy. Semin Radiat Oncol (2013) 0.85
Radiobiological studies on the 65 MeV therapeutic proton beam at Nice using human tumour cells. Int J Radiat Biol (2000) 0.85
Conservative treatment of uveal melanoma: local recurrence after proton beam therapy. Int J Radiat Oncol Biol Phys (1989) 0.84
Response of a human melanoma cell line to low and high ionizing radiation. Ann N Y Acad Sci (2007) 0.84
Gamma-radiation (GR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo. Cancer Biol Ther (2008) 0.84
Deficiency in homologous recombination renders Mammalian cells more sensitive to proton versus photon irradiation. Int J Radiat Oncol Biol Phys (2013) 0.83
Effect of proton beam on blood vessel formation in early developing zebrafish (Danio rerio) embryos. Arch Pharm Res (2008) 0.83
Biological effectiveness of high-energy protons: target fragmentation. Radiat Res (1991) 0.83
Radiation tolerance of the rat spinal cord after 6 and 18 fractions of photons and carbon ions: experimental results and clinical implications. Int J Radiat Oncol Biol Phys (2006) 0.82
A microdosimetric-kinetic theory of the dependence of the RBE for cell death on LET. Med Phys (1998) 0.82
Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 0.82
Total reaction and partial cross section calculations in proton-nucleus (Zt <= 26) and nucleus-nucleus reactions (Zp and Zt <= 26). Phys Rev C Nucl Phys (1993) 0.82
Particle radiation alters expression of matrix metalloproteases resulting in ECM remodeling in human lens cells. Radiat Environ Biophys (2007) 0.81
Response of thyroid follicular cells to gamma irradiation compared to proton irradiation: II. The role of connexin 32. Radiat Res (2002) 0.81
RBE variation as a function of depth in the 200-MeV proton beam produced at the National Accelerator Centre in Faure (South Africa). Radiother Oncol (1997) 0.81